RVMD peer analysis
Revolution Medicines (RVMD) against its competitors: price, today's move, 1-year return and market value side by side.
RVMD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDTX Black Diamond | $1.78 | -4.30% | -53.40% | $102.27M |
| ELVN Enliven Therapeutics | $44.49 | 0.54% | 85.61% | – |
| ERAS Erasca | $14.19 | -1.11% | 476.83% | – |
| GLUE Monte Rosa Therapeutics | $10.61 | -1.39% | -18.45% | – |
| IDYA IDEAYA Biosciences | $31.43 | -1.64% | -0.52% | $3.08B |
| NRIX Nurix Therapeutics | $25.77 | -3.84% | 101.64% | – |
| ORIC Oric | $9.21 | -0.38% | -31.00% | $957.75M |
| RLAY Relay Therapeutics | $17.61 | -4.03% | 139.92% | – |
| TNGX Tango Therapeutics | $22.62 | -0.44% | 183.81% | – |
| VSTM Verastem | $9.69 | -0.62% | 4.98% | $1.18B |
| RVMD Revolution Medicines | $190.84 | -0.25% | 224.17% | $41.00B |
- RVMD's peers: BDTX (Black Diamond), ELVN (Enliven Therapeutics), ERAS (Erasca), GLUE (Monte Rosa Therapeutics), IDYA (IDEAYA Biosciences), NRIX (Nurix Therapeutics), ORIC (Oric), RLAY (Relay Therapeutics).
Updated 2026-11-02 17:14 UTC